Pressure Biosciences Inc (PBIO) financial statements (2021 and earlier)

Company profile

Business Address 14 NORFOLK AVENUE
SOUTH EASTON, MA 02375
State of Incorp. MA
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 000000
Cash and cash equivalents 000000
Receivables 000000
Inventory, net of allowances, customer advances and progress billings, including: 000111
Inventory 111111
Other undisclosed inventory, net of allowances, customer advances and progress billings (1)(1)(1)   
Prepaid expense   0000
Intangible current assets 111   
Other undisclosed current assets 000000
Total current assets: 121212
Noncurrent Assets
Operating lease, right-of-use asset 0
Property, plant and equipment 000000
Long-term investments and receivables 00000 
Long-term investments 00000 
Intangible assets, net (including goodwill) 111  2
Intangible assets, net (excluding goodwill) 111  2
Other undisclosed noncurrent assets  0   (2)
Total noncurrent assets: 111000
TOTAL ASSETS: 222222
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 322222
Accounts payable 111011
Accrued liabilities 211111
Employee-related liabilities 000000
Deferred revenue 0
Debt 8513501
Derivative instruments and hedges, liabilities    230
Due to related parties 00    
Deferred revenue and credits0000
Contract with customer, liability0
Other liabilities 312   
Other undisclosed current liabilities   0141
Total current liabilities: 148179104
Noncurrent Liabilities
Long-term debt and lease obligation    10 
Long-term debt, excluding current maturities    10 
Liabilities, other than long-term debt 0 0000
Deferred revenue and credits0000
Deferred revenue 0
Other undisclosed noncurrent liabilities  0 0  
Total noncurrent liabilities: 000100
Total liabilities: 1491710104
Stockholders' equity
Stockholders' equity attributable to parent, including: (12)(6)(15)(8)(8)(2)
Common stock 000000
Additional paid in capital 444031272625
Accumulated other comprehensive loss     (0) 
Accumulated deficit (79)(66)(55)(42)(40)(32)
Warrants and rights outstanding 232010655
Other undisclosed stockholders' equity attributable to parent 000000
Total stockholders' equity: (12)(6)(15)(8)(8)(2)
TOTAL LIABILITIES AND EQUITY: 222222

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 222221
Revenue, net2221
Cost of revenue
(Cost of Goods and Services Sold)
 (1)(1)(1)(1)(1) 
Gross profit: 111111
Operating expenses (8)(7)(7)(6)(5)(5)
Other undisclosed operating income 11111 
Operating loss: (6)(4)(5)(4)(4)(3)
Nonoperating income (expense) (6)(5)(6)1(4)(1)
Investment income, nonoperating      (1)
Interest and debt expense (1)00(0)(4) 
Loss from continuing operations before income taxes: (13)(9)(11)(3)(12)(5)
Income tax benefit 0     
Loss before gain (loss) on sale of properties: (12)(9)(11)(3)(12)(5)
Other undisclosed net loss (3)(14)    
Net loss: (16)(23)(11)(3)(12)(5)
Other undisclosed net income (loss) attributable to parent 414(0)04 
Net loss attributable to parent: (12)(10)(11)(3)(7)(5)
Preferred stock dividends and other adjustments (2)(1)  (0)(2)
Other undisclosed net loss available to common stockholders, basic (3)(13)    
Net loss available to common stockholders, diluted: (16)(23)(11)(3)(7)(6)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (16)(23)(11)(3)(12)(5)
Comprehensive loss: (16)(23)(11)(3)(12)(5)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (0)04 
Comprehensive loss, net of tax, attributable to parent: (16)(23)(11)(3)(8)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: